Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 9/20 | 0.34 |
| ▸ | CA2 | P00918 | 9/20 | 0.34 |
| ▸ | CA9 | Q16790 | 9/20 | 0.34 |
| ▸ | CA4 | P22748 | 8/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3492063 | 0.89 | ALDH1A1 (0.41) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3493665 | 0.89 | BCL2 (0.38) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL13341218 | 0.89 | PARP1 (0.39) | SMN1; SMN2MAPTTP53 | |
| SCHEMBL3494849 | 0.87 | HCRTR1 (0.46) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3493841 | 0.86 | ALDH1A1 (0.39) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3495223 | 0.86 | CNR2 (0.38) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3495662 | 0.86 | CA1 (0.42) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3493192 | 0.85 | CNR2 (0.38) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3491924 | 0.85 | ALDH1A1 (0.41) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT | |
| SCHEMBL3495754 | 0.85 | POLB (0.38) | SMN1; SMN2ALDH1A1NOTUMRAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100121048-A1 | Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121048-A1 | Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension | REN, AGTR1, AGTR2 | SMN1; SMN2 4730/4885ALDH1A1 1062/4885NOTUM 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.